Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
328.7 INR | -1.94% | -0.18% | -19.09% |
Mar. 19 | Venus Remedies Secures Marketing Authorizations in Ukraine for Three Oncology Drugs | MT |
Mar. 08 | Venus Remedies Gets Ukraine's Marketing Approval for Three Oncology Products | MT |
Sales 2022 | 5.99B 71.78M | Sales 2023 | 5.56B 66.61M | Capitalization | 2.16B 25.96M |
---|---|---|---|---|---|
Net income 2022 | 407M 4.88M | Net income 2023 | 266M 3.19M | EV / Sales 2022 | 0.6 x |
Net cash position 2022 | 4.11M 49.24K | Net cash position 2023 | 291M 3.48M | EV / Sales 2023 | 0.34 x |
P/E ratio 2022 |
8.71
x | P/E ratio 2023 |
8.15
x | Employees | 998 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 55.32% |
1 day | -1.94% | ||
1 week | -0.18% | ||
Current month | +0.87% | ||
1 month | +1.70% | ||
3 months | -16.05% | ||
6 months | +27.68% | ||
Current year | -19.09% |
Managers | Title | Age | Since |
---|---|---|---|
Ashutosh Jain
CEO | Chief Executive Officer | 46 | 07-04-30 |
Pawan Chaudhary
CHM | Chairman | 59 | 89-09-14 |
Jitendra Singh
ADM | Chief Administrative Officer | - | 98-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gilbert Wenzel
BRD | Director/Board Member | 67 | - |
Peeyush Jain
BRD | Director/Board Member | 52 | - |
Ashutosh Jain
CEO | Chief Executive Officer | 46 | 07-04-30 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 328.7 | -1.94% | 38 623 |
24-04-18 | 335.2 | +2.38% | 33,573 |
24-04-16 | 327.4 | +1.90% | 31,392 |
24-04-15 | 321.3 | -2.43% | 34,210 |
24-04-12 | 329.3 | -3.12% | 23,392 |
Delayed Quote NSE India S.E., April 19, 2024 at 07:43 am EDT
More quotes1st Jan change | Capi. | |
---|---|---|
+27.97% | 672B | |
+23.72% | 550B | |
-7.02% | 351B | |
+14.85% | 317B | |
+6.25% | 292B | |
+2.34% | 211B | |
-0.26% | 203B | |
-11.81% | 144B | |
-8.80% | 141B |
- Stock Market
- Equities
- VENUSREM Stock
- VENUSREM Stock